SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-23-005175
Filing Date
2023-07-31
Accepted
2023-07-31 17:18:17
Documents
71
Period of Report
2023-04-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT pharmacyte_i10k-043023.htm   iXBRL 10-K 1786238
2 LIST OF SUBSIDIARIES pharmacyte_ex2101.htm EX-21.1 2766
3 CONSENT pharmacyte_ex2301.htm EX-23.1 1800
4 CERTIFICATION pharmacyte_ex3101.htm EX-31.1 8945
5 CERTIFICATION pharmacyte_ex3102.htm EX-31.2 8959
6 CERTIFICATION pharmacyte_ex3201.htm EX-32.1 4544
7 CERTIFICATION pharmacyte_ex3202.htm EX-32.2 4642
  Complete submission text file 0001683168-23-005175.txt   6366407

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE pmcb-20230430.xsd EX-101.SCH 41128
9 XBRL CALCULATION FILE pmcb-20230430_cal.xml EX-101.CAL 47500
10 XBRL DEFINITION FILE pmcb-20230430_def.xml EX-101.DEF 179693
11 XBRL LABEL FILE pmcb-20230430_lab.xml EX-101.LAB 308782
12 XBRL PRESENTATION FILE pmcb-20230430_pre.xml EX-101.PRE 284257
65 EXTRACTED XBRL INSTANCE DOCUMENT pharmacyte_i10k-043023_htm.xml XML 858014
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-40699 | Film No.: 231128450
SIC: 2836 Biological Products, (No Diagnostic Substances)